UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Details
Datensatz exportieren als...
BibTeX
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
CA: a cancer journal for clinicians, 2017-11, Vol.67 (6), p.472-492
Gershenwald, Jeffrey E.
Scolyer, Richard A.
Hess, Kenneth R.
Sondak, Vernon K.
Long, Georgina V.
Ross, Merrick I.
Lazar, Alexander J.
Faries, Mark B.
Kirkwood, John M.
McArthur, Grant A.
Haydu, Lauren E.
Eggermont, Alexander M. M.
Flaherty, Keith T.
Balch, Charles M.
Thompson, John F.
Atkins, Michael B.
Barnhill, Raymond L.
Bilimoria, Karl Y.
Buzaid, Antonio C.
Byrd, David R.
Cochran, Alistair J.
Elder, David E.
Garbe, Claus
Gardner, Julie M.
Gimotty, Phyllis A.
Halpern, Allan C.
Johnson, Timothy M.
Lee, Anne W. M.
Mihm Jr, Martin C.
Prieto, Victor G.
Sober, Arthur J.
Wong, Sandra L.
Delman, Keith A.
Santinami, Mario
Maurichi, Andrea
Nagore, Eduardo
Gyorki, David E.
Henderson, Michael
Stratigos, Alexander J.
Gogas, Helen
Rossi, Carlo Riccardo
Sommariva, Antonio
2017
Details
Autor(en) / Beteiligte
Gershenwald, Jeffrey E.
Scolyer, Richard A.
Hess, Kenneth R.
Sondak, Vernon K.
Long, Georgina V.
Ross, Merrick I.
Lazar, Alexander J.
Faries, Mark B.
Kirkwood, John M.
McArthur, Grant A.
Haydu, Lauren E.
Eggermont, Alexander M. M.
Flaherty, Keith T.
Balch, Charles M.
Thompson, John F.
Atkins, Michael B.
Barnhill, Raymond L.
Bilimoria, Karl Y.
Buzaid, Antonio C.
Byrd, David R.
Cochran, Alistair J.
Elder, David E.
Garbe, Claus
Gardner, Julie M.
Gimotty, Phyllis A.
Halpern, Allan C.
Johnson, Timothy M.
Lee, Anne W. M.
Mihm Jr, Martin C.
Prieto, Victor G.
Sober, Arthur J.
Wong, Sandra L.
Delman, Keith A.
Santinami, Mario
Maurichi, Andrea
Nagore, Eduardo
Gyorki, David E.
Henderson, Michael
Stratigos, Alexander J.
Gogas, Helen
Rossi, Carlo Riccardo
Sommariva, Antonio
Titel
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Ist Teil von
CA: a cancer journal for clinicians, 2017-11, Vol.67 (6), p.472-492
Ort / Verlag
United States: Wiley Subscription Services, Inc
Erscheinungsjahr
2017
Link zum Volltext
Quelle
Wiley Online Library Journals Frontfile Complete
Beschreibungen/Notizen
Answer questions and earn CME/CNE To update the melanoma staging system of the American Joint Committee on Cancer (AJCC) a large database was assembled comprising >46,000 patients from 10 centers worldwide with stages I, II, and III melanoma diagnosed since 1998. Based on analyses of this new database, the existing seventh edition AJCC stage IV database, and contemporary clinical trial data, the AJCC Melanoma Expert Panel introduced several important changes to the Tumor, Nodes, Metastasis (TNM) classification and stage grouping criteria. Key changes in the eighth edition AJCC Cancer Staging Manual include: 1) tumor thickness measurements to be recorded to the nearest 0.1 mm, not 0.01 mm; 2) definitions of T1a and T1b are revised (T1a, <0.8 mm without ulceration; T1b, 0.8‐1.0 mm with or without ulceration or <0.8 mm with ulceration), with mitotic rate no longer a T category criterion; 3) pathological (but not clinical) stage IA is revised to include T1b N0 M0 (formerly pathologic stage IB); 4) the N category descriptors “microscopic” and “macroscopic” for regional node metastasis are redefined as “clinically occult” and “clinically apparent”; 5) prognostic stage III groupings are based on N category criteria and T category criteria (ie, primary tumor thickness and ulceration) and increased from 3 to 4 subgroups (stages IIIA‐IIID); 6) definitions of N subcategories are revised, with the presence of microsatellites, satellites, or in‐transit metastases now categorized as N1c, N2c, or N3c based on the number of tumor‐involved regional lymph nodes, if any; 7) descriptors are added to each M1 subcategory designation for lactate dehydrogenase (LDH) level (LDH elevation no longer upstages to M1c); and 8) a new M1d designation is added for central nervous system metastases. This evidence‐based revision of the AJCC melanoma staging system will guide patient treatment, provide better prognostic estimates, and refine stratification of patients entering clinical trials. CA Cancer J Clin 2017;67:472‐492. © 2017 American Cancer Society.
Sprache
Englisch
Identifikatoren
ISSN: 0007-9235
eISSN: 1542-4863
DOI: 10.3322/caac.21409
Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5978683
Format
–
Schlagworte
American Joint Committee on Cancer (AJCC)
,
Cancer
,
Central nervous system
,
Clinical trials
,
Evidence-based medicine
,
Humans
,
L-Lactate dehydrogenase
,
Lactic acid
,
Lymph nodes
,
Lymphatic Metastasis
,
Medical prognosis
,
Melanoma
,
Melanoma - epidemiology
,
Melanoma - pathology
,
Metastases
,
Metastasis
,
Microsatellites
,
Neoplasm Staging - standards
,
pathology
,
Practice Guidelines as Topic
,
prognosis
,
Registries
,
Revisions
,
Satellites
,
Skin Neoplasms - epidemiology
,
Skin Neoplasms - pathology
,
Societies, Medical
,
staging
,
survival
,
TNM classification
,
United States - epidemiology
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX